ENMC Encore Medical

AUSTIN, Texas, July 19 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) announced today that the Company will release second quarter 2006 financial results prior to the opening of trading on Monday, July 31, 2006. The Company will then host a conference call beginning at 10 am Eastern Time to discuss the results of operations and recent business developments. A live webcast of the conference can be accessed from Encore's website http://www.encoremed.com/ . If you are unable to participate during the live webcast, an audio archive will be available shortly after the call and will be accessible from Encore's website for approximately 30 days. A telephonic replay of the conference call will also be available for one week after the call by dialing (domestic) (800) 642-1687 or (international) (706) 645-9291 and requesting conference ID #3085874. Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries. Through its Orthopedic Rehabilitation Division, Encore is a leading distributor of electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products and spinal implants. For more information, visit http://www.encoremed.com/ . Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties, such as the timely availability of new products, the impacts of competitive products and pricing, the ability to continue to obtain long-term financing, and other risks and uncertainties set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. Contact: Davis Henley, Vice President - Business Development (512) 832-9500 DATASOURCE: Encore Medical Corporation CONTACT: Davis Henley, Vice President - Business Development, of Encore Medical Corporation, +1-512-832-9500, or Web site: http://www.encoremed.com/

Copyright